Hyperacute thrombolysis with recombinant tissue plasminogen activator of acute ischemic stroke: Feasibility and effectivity from an Indian perspective

Annals of Indian Academy of Neurology

Volumn 11, Issue 4, 2008, Pages 221-224

  Sharma, S ^a   Sharma, Nalini ^a  

^a S R M S Institute of Medical Sciences   (India)

Author keywords

r tpa; Stroke; Thrombolysis

Indexed keywords

ALTEPLASE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; FEASIBILITY STUDY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INDIA; MALE; RECURRENT DISEASE;

EID: 58149152666     PISSN: 09722327     EISSN: 19983549     Source Type: Journal    
DOI: 10.4103/0972-2327.44556     Document Type: Article

References (15)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Eng J Med 1995;333:1581-7.
2. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, et al. Association of outcome with early stroke treatment: Pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet 2004;363:768-74.
3. Katzan IL, Hammer MD, Furlan AJ, Hixson ED, Nadzam DM; Cleveland Clinic Health System Stroke Quality Improvement Team. Quality improvement and tissue - type plasminogen activator for acute ischemic stroke: A Cleveland update. Stroke 2003;34:799-800.
4. Padma MV, Singh MB, Bhatia R, Srivastava A, Tripathi M, Shukla G, et al. Hyper acute thrombolysis with IV rtPA of acute ischemic stroke: Efficacy and safety of 54 patients at a tertiary referral center in a developing country. Neurol India 2007;55:46-9.
5. Kaste M. Thrombolysis in ischemic stroke-present and future: Role of combined therapy. Cerebrovasc Dis 2001;11:55-9.
6. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Practice advisory: Thrombolytic therapy for acute ischemic stroke - summary statement. Neurology 1996;47:835-9.
7. Adams HP Jr, Brott TG, Furlan AJ, Gomez CR, Grotta J, Helgason CM, et al. Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke, A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1996;94:1167-74.
8. Smith RW, Scott PA, Grant RJ, Chudnofsky CR, Frederksen SM. Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: A retrospective analysis. Acad Emerg Med 1999;6:618-25.
9. Bravata DM, Kim N, Concato JK, Krumholz HM, Brass LM. Thrombolysis for acute stroke n routine clinical practice. Arch Intern Med 2002;162:1994-2001.
10. Tanne D, Bates VE, Verro P, Kasner SE, Binder JR, Patel SC, et al. Initial clinical Experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey. Neurology 1999;53:424-7.
11. Clark WM, Lutsep HL. Medical treatment strategies: intravenous thrombolysis, neuronal protection and anti- reperfusion injury agents. Neuroimaging Clin N Am 1999;9:465-73.
12. Aklins PT, Delemos C, Wentworth D, Byer J, Schorer SJ, Atkinson RP. Can emergency department physician safely and effectively initiate thrombolysis for acute ischemic stroke? Neurology 2000;55:1801-5.
13. Wang DZ, Rose JA, Honings DS, Garwacki DJ, Milbrandt JC. Treating acute stroke patients with intravenous tPA: The OSF stroke network experience. Stroke 2000;31:77-81.
14. Koenneeke HC, Nohr R, Leister S, Marx P. Intravenous tPA for ischemic stroke team performance over time, safety and efficacy in a single - center, 2- year experience. Stroke 2001;32:1074-8.
15. Schmulling S, Grand M, Rudolf J, Heis WD. One year follow up in acute stroke patients treated with rt- PA in clinical routine. Stroke 2000;31:1552-4.